CD24hi/CD38hi/CD19+ Bregs were found in higher density in comparison with CD19+ B-cells in HNSCC TME and this regulatory phenotype preferentially localized in tumor tissue rather than in PBMCs isolated from the same cases [17]. Here, CD19 is linked to head and neck squamous cell carcinoma.